Business Standard

Dr Reddy's Laboratories standalone net profit declines 20.76% in the March 2018 quarter

Image

Capital Market

Sales rise 7.52% to Rs 2476.60 crore

Net profit of Dr Reddy's Laboratories declined 20.76% to Rs 176.70 crore in the quarter ended March 2018 as against Rs 223.00 crore during the previous quarter ended March 2017. Sales rose 7.52% to Rs 2476.60 crore in the quarter ended March 2018 as against Rs 2303.40 crore during the previous quarter ended March 2017.

For the full year,net profit declined 59.04% to Rs 566.90 crore in the year ended March 2018 as against Rs 1384.10 crore during the previous year ended March 2017. Sales declined 3.38% to Rs 9302.60 crore in the year ended March 2018 as against Rs 9628.10 crore during the previous year ended March 2017.

 
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales2476.602303.40 8 9302.609628.10 -3 OPM %13.1813.43 -14.3018.13 - PBDT385.50353.00 9 1471.102279.60 -35 PBT195.50163.40 20 697.001544.50 -55 NP176.70223.00 -21 566.901384.10 -59

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 22 2018 | 3:55 PM IST

Explore News